Skip to Content
Merck
  • Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase.

Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase.

Journal of medicinal chemistry (2006-09-29)
Jürgen Bosch, Mark A Robien, Christopher Mehlin, Erica Boni, Aaron Riechers, Frederick S Buckner, Wesley C Van Voorhis, Peter J Myler, Elizabeth A Worthey, George DeTitta, Joseph R Luft, Angela Lauricella, Stacey Gulde, Lori A Anderson, Oleksandr Kalyuzhniy, Helen M Neely, Jenni Ross, Thomas N Earnest, Michael Soltis, Lori Schoenfeld, Frank Zucker, Ethan A Merritt, Erkang Fan, Christophe L M J Verlinde, Wim G J Hol
ABSTRACT

The 1.8 A resolution de novo structure of nucleoside 2-deoxyribosyltransferase (EC 2.4.2.6) from Trypanosoma brucei (TbNDRT) has been determined by SADa phasing in an unliganded state and several ligand-bound states. This enzyme is important in the salvage pathway of nucleoside recycling. To identify novel lead compounds, we exploited "fragment cocktail soaks". Out of 304 compounds tried in 31 cocktails, four compounds could be identified crystallographically in the active site. In addition, we demonstrated that very short soaks of approximately 10 s are sufficient even for rather hydrophobic ligands to bind in the active site groove, which is promising for the application of similar soaking experiments to less robust crystals of other proteins.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Nucleoside Deoxyribosyltransferase II from Lactobacillus leichmanii, lyophilized powder, recombinant, expressed in E. coli
Sigma-Aldrich
5-Aminoisoquinoline, 99%